-
Innovation Ranking
Innovation Ranking – Marinus Pharmaceuticals Inc
Marinus Pharmaceuticals Inc (Marinus Pharmaceuticals) is a biopharmaceutical company. It discovers, develops and commercializes medicines for the treatment of rare genetic epilepsies and other seizure disorders. The company’s product is Ganaxolone, a novel gamma-aminobutyric acid (GABA) receptor modulator, which is developed in intravenous (IV) and oral formulations. Marinus Pharmaceuticals carries out research and development, educational grants, and other services. It markets products under the brand name Ztalmy. The company product help in the treatment of acute and chronic care settings,...
-
Innovation Ranking
Innovation Ranking – KPC Pharmaceuticals Inc
KPC Pharmaceuticals Inc (KPC) is a pharmaceutical company. It is a manufacturer and seller of botanical drugs and other pharmaceutical products. The company offers products that comprise panax notoginseng, artemether, gastrodine, Chinese medicines and special botanical drugs. It provides products under tablet, capsule and injection. KPC’s drugs are used for the treatment of central nervous system disorders, cardiovascular, cardio-cerebral-vascular, chronic disease, disorders and malaria. It also offers research and development, marketing, production, commercial wholesale and international marketing services. The company...
-
Innovation Ranking
Innovation Ranking – Pieris Pharmaceuticals Inc
Pieris Pharmaceuticals Inc (Pieris) is a clinical-stage biotechnology company that carries out the discovery and development of anticalin-based drugs. The company’s pipeline product includes inhaled IL-4Rα antagonist Anticalin protein. It offers drug candidates such as PRS-060/AZD1402, PRS-220, PRS-440, PRS-342 and PRS-352, among others. Pieris also carries out AstraZenca programs and Genetech programs against respiratory diseases. The company offers therapeutics for the treatment of respiratory diseases, oncology and other diseases. It leverages Anticalin technology platform to develop and advance its pipeline...
-
Innovation Ranking
Innovation Ranking – Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc (Corvus Pharma) is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of immuno-oncology therapies that are used for treating cancer. Corvus Pharma's product candidate is CPI-444, an oral, small molecule antagonist of the A2A receptor that is in phase I clinical trial for adenosine, an immune checkpoint. The company also develops a product candidate, an anti-CD73 monoclonal antibody that inhibits the production of adenosine produced by the tumor cells. Corvus Pharma’s product pipeline...
-
Innovation Ranking
Innovation Ranking – TRACON Pharmaceuticals Inc
TRACON Pharmaceuticals Inc (TRACON) is a biopharmaceutical company. It develops and commercializes targeted therapies for cancer, age-related macular degeneration and fibrotic diseases. The company offers pipeline products such as TRC105, TRC102, TJ004309, TRC253, TRC694, and TRC205. Its lead product TRC105, is an anti-endoglin antibody that is being developed for the treatment of multiple solid tumor types in combination with VEGF inhibitors. TRC102 is a small molecule that is in clinical development for the treatment of lung cancer and glioblastoma. In...
-
Innovation Ranking
Innovation Ranking – Agios Pharmaceuticals Inc
Agios Pharmaceuticals Inc (Agios) is a biopharmaceutical company. The company focuses on the discovery and development of investigational medicines for the treatment of cancer and rare genetic metabolic disorders. Its pipeline products include AG-946, a novel, next-generation PKR activator used for the treatment of hemolytic anemias and other indications, including SCD and anemia associated with low- to intermediate-risk myelodysplastic syndrome. The company also provides Mitapivat which is an activator of both wild-type and a variety of mutant pyruvate kinase that...
-
Innovation Ranking
Innovation Ranking – Eagle Pharmaceuticals Inc
Eagle Pharmaceuticals Inc (Eagle) is a specialty pharmaceutical company that offers proprietary pharmaceutical injectables in the therapy areas of critical care, oncology, and various orphan diseases. The company’s key commercial products encompass pharmaceutical injectables, including Ryanodex for exertional heatstroke; Bendeka, and Belrapzo, both for the treatment of chronic lymphocytic leukemia (CLL), and indolent B-cell non-Hodgkin’s lymphoma (NHL). Pipeline products of the company include EP-4104 (dantrolene sodium) for exertional heat stroke (EHS) and nerve agent exposure; EA-114 (fulvestrant) for the treatment...
-
Innovation Ranking
Innovation Ranking – X4 Pharmaceuticals Inc
X4 Pharmaceuticals Inc, formerly Arsanis Inc, is a clinical stage bio pharmaceutical company that develops oral, small molecule therapeutics to treat cancer and rare diseases. The company’s pipeline products include Mavorixafor, an allosteric inhibitor of CXCR4 for the treatment of Warts, Hypogammaglobulinemia, Immunodeficiency and Myelokathexis (WHIM) syndrome X4P-002 and X4P-003, small molecule antagonists of chemokine receptor CXCR4 for treating glioblastoma multiforme and primary immune deficiencies (PI's). The company is developing oral allosteric antagonists of CXCR4 in order to block overstimulation...
-
Innovation Ranking
Innovation Ranking – Intercept Pharmaceuticals Inc
Intercept Pharmaceuticals Inc (Intercept) is a biopharmaceutical company that researches, develops, and commercializes treatments for non-viral, progressive liver diseases. It develops products using proprietary bile acid chemistry. The company’s lead product candidate, obeticholic acid (OCA), is a bile acid analog and first-in-class agonist of the farnesoid X receptor. The company is advancing OCA for the treatment of various other liver diseases. The company harnesses its proprietary bile acid chemistry to develop innovative drugs. It is also advancing INT-787, an FXR...
-
Innovation Ranking
Innovation Ranking – Dechra Pharmaceuticals Plc
Dechra Pharmaceuticals Plc (Dechra) is a manufacturer and distributor of veterinary pharmaceutical products. The company's product portfolio includes amoxicillin, carprovet, cefpoderm, clavacillin, dexmedesed, enrofloxacin, enroquin, gentaCalm, isoflurane_x000D_ laverdia, marboquim, meloxicam, muricin, ophtHAvet, orthokine , osurnia, rederox, sevoflurane, tzed, vetivex, vetoryl, vetropolycin , zenalpha and zycortal, among others. Its products are used in the therapeutic areas of anesthesia and analgesia, dermatology, pet diets and nutrition, endocrinology, cardiology, exotics and fluid therapy. Dechra manufactures human and veterinary pharmaceutical products for third-party customers....